Regeneron · 6 hours ago
Summer 2026 PhD Intern – Precision Medicine & Imaging
TARRYTOWN
Internship
Onsite
Intern
$19/hr - $54/hr
Start in 2026 SpringRegeneron Pharmaceuticals is seeking a Summer 2026 PhD Intern in their Precision Medicine and Imaging Department. The intern will work on developing imaging biomarkers for neurological diseases, focusing on projects related to MRI, SPECT, and PET imaging.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Conduct literature reviews
Develop hypotheses
Process imaging data from public databases
Conduct statistical analyses
Prepare presentations
Collaborate with cross-functional teams
Qualification
Required
Currently pursuing a PhD in Neuroscience, Biomedical Engineering, Biology, or other related field
Degree in biomedical engineering or life sciences with a background in imaging
To be considered for this opportunity, you must be enrolled in, or accepted to, an academic program pursuing a PhD degree and be completing your degree in December 2026 or later
Commit to 40 hours per week from May/June - August 2026
Preferred
Experience in programming (e.g., R, Python, Matlab), image processing, and statistical analysis is preferred
A cumulative GPA of 3.0 is preferred
Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community is also preferred
Benefits
Health and wellness programs
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Founded in 1988
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
2026-01-13
2026-01-09
Company data provided by crunchbase